From October 1, 2023 to December 31, 2023, the company has repurchased 5,983,233 shares, representing 0.99% for $444.26 million. With this, the company has completed the repurchase of 18,921,321 shares, representing 3.09% for $1,450.43 million under the buyback announced on July 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.16 USD | +4.28% | +5.96% | +18.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.24% | 54.33B | |
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+1.67% | 64.85B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B | |
+28.26% | 32.41B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on July 28, 2022.